DK193588D0 - Anvendelser af dopaminagonister - Google Patents
Anvendelser af dopaminagonisterInfo
- Publication number
- DK193588D0 DK193588D0 DK193588A DK193588A DK193588D0 DK 193588 D0 DK193588 D0 DK 193588D0 DK 193588 A DK193588 A DK 193588A DK 193588 A DK193588 A DK 193588A DK 193588 D0 DK193588 D0 DK 193588D0
- Authority
- DK
- Denmark
- Prior art keywords
- dopaminagonists
- applications
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB878708626A GB8708626D0 (en) | 1987-04-10 | 1987-04-10 | Indolophenanthridines |
GB878708898A GB8708898D0 (en) | 1987-04-14 | 1987-04-14 | Indolophenanthridines |
GB878710062A GB8710062D0 (en) | 1987-04-28 | 1987-04-28 | Indolophenanthridines |
GB878720366A GB8720366D0 (en) | 1987-08-28 | 1987-08-28 | Dopamine d1 receptor agonists |
Publications (2)
Publication Number | Publication Date |
---|---|
DK193588D0 true DK193588D0 (da) | 1988-04-08 |
DK193588A DK193588A (da) | 1988-10-11 |
Family
ID=27449909
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK193588A DK193588A (da) | 1987-04-10 | 1988-04-08 | Anvendelser af dopaminagonister |
Country Status (11)
Country | Link |
---|---|
US (1) | US4855306A (da) |
JP (1) | JPS63258819A (da) |
KR (1) | KR880012227A (da) |
AU (1) | AU1440088A (da) |
DE (1) | DE3811274A1 (da) |
DK (1) | DK193588A (da) |
FR (1) | FR2613623A1 (da) |
GB (1) | GB2205495A (da) |
IT (1) | IT1219906B (da) |
NL (1) | NL8800823A (da) |
SE (1) | SE8801275L (da) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69838789T2 (de) * | 1997-03-12 | 2008-10-30 | Suzanne Cambridge de la Monte | Verfahren zur behandlung oder prävention der alzheimerischen krankheit |
US20040058873A1 (en) * | 1998-03-12 | 2004-03-25 | Esmond Robert W. | Method for treating or preventing Alzheimer's disease |
US6362371B1 (en) * | 1998-06-08 | 2002-03-26 | Advanced Medicine, Inc. | β2- adrenergic receptor agonists |
DE10148233A1 (de) * | 2001-09-28 | 2003-04-10 | Boehringer Ingelheim Pharma | Verbindungen zur Reduzierung übermäßiger Nahrungsaufnahme |
US20050215552A1 (en) * | 2002-05-17 | 2005-09-29 | Gadde Kishore M | Method for treating obesity |
KR101072885B1 (ko) | 2002-05-17 | 2011-10-17 | 듀크 유니버시티 | 비만치료방법 |
DE10312809A1 (de) * | 2003-03-21 | 2004-09-30 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pramipexol zur Reduzierung übermäßiger Nahrungsaufnahme bei Kindern |
US20040266794A1 (en) * | 2003-03-21 | 2004-12-30 | Boehringer Ingelheim International Gmbh | Pramipexole for the reduction of excessive food intake for children |
ATE388698T1 (de) | 2003-04-29 | 2008-03-15 | Orexigen Therapeutics Inc | Zusammensetzungen zur beeinflussung des gewichtsverlusts |
WO2004103262A2 (en) * | 2003-05-22 | 2004-12-02 | Yeda Research And Development Co. Ltd. | Dopamine and agonists and antagonists thereof for modulation of suppressive activity of cd4+cd25+ regulatory t cells |
WO2005070461A2 (en) * | 2004-01-13 | 2005-08-04 | Duke University | Compositions of an anticonvulsant and an antipsychotic drug for affecting weight loss |
US7713959B2 (en) * | 2004-01-13 | 2010-05-11 | Duke University | Compositions of an anticonvulsant and mirtazapine to prevent weight gain |
RU2006139930A (ru) * | 2004-05-03 | 2008-06-10 | Дюк Юниверсити (Сша/Сша) (Us) | Составы для содействия снижению веса |
US20080306019A1 (en) * | 2005-05-03 | 2008-12-11 | Booze Rosemarie M | Dopamine Receptor Agonists in the Treatment and Prevention of Hiv-Induced Dementia |
PT2135603E (pt) | 2005-11-22 | 2013-04-03 | Orexigen Therapeutics Inc | Composições e métodos para aumentar a sensibilidade à insulina |
US8916195B2 (en) | 2006-06-05 | 2014-12-23 | Orexigen Therapeutics, Inc. | Sustained release formulation of naltrexone |
KR20090090316A (ko) | 2006-11-09 | 2009-08-25 | 오렉시젠 세러퓨틱스 인크. | 체중 감량 약물을 투여하기 위한 단위 용량 팩키지 및 투여 방법 |
JP2010509367A (ja) | 2006-11-09 | 2010-03-25 | オレキシジェン・セラピューティクス・インコーポレーテッド | 積層製剤 |
JP2011521973A (ja) | 2008-05-30 | 2011-07-28 | オレキシジェン・セラピューティクス・インコーポレーテッド | 内臓脂肪の状態を処置するための方法 |
RU2483082C1 (ru) * | 2009-08-27 | 2013-05-27 | Дайкин Индастриз, Лтд. | Технологическая добавка, композиция для формования, маточная смесь технологической добавки и формовое изделие |
KR20120124423A (ko) | 2010-01-11 | 2012-11-13 | 오렉시젠 세러퓨틱스 인크. | 주우울증 환자들에 있어서 체중 감량 치료를 제공하는 방법 |
PT3730132T (pt) | 2012-06-06 | 2022-08-16 | Nalpropion Pharmaceuticals Llc | Composição para utilização num método de tratamento de excesso de peso e obesidade em doentes com alto risco cardiovascular |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3402392A1 (de) * | 1984-01-25 | 1985-08-01 | Sandoz-Patent-GmbH, 7850 Lörrach | Neue ergolinderivate, deren herstellung und deren verwendung |
-
1988
- 1988-03-31 NL NL8800823A patent/NL8800823A/nl not_active Application Discontinuation
- 1988-04-01 FR FR8804499A patent/FR2613623A1/fr not_active Withdrawn
- 1988-04-02 DE DE3811274A patent/DE3811274A1/de not_active Withdrawn
- 1988-04-05 IT IT47814/88A patent/IT1219906B/it active
- 1988-04-07 US US07/178,668 patent/US4855306A/en not_active Expired - Fee Related
- 1988-04-07 GB GB08808125A patent/GB2205495A/en active Pending
- 1988-04-08 SE SE8801275A patent/SE8801275L/ not_active Application Discontinuation
- 1988-04-08 AU AU14400/88A patent/AU1440088A/en not_active Abandoned
- 1988-04-08 DK DK193588A patent/DK193588A/da not_active Application Discontinuation
- 1988-04-09 KR KR1019880004023A patent/KR880012227A/ko not_active Application Discontinuation
- 1988-04-09 JP JP63088033A patent/JPS63258819A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
AU1440088A (en) | 1988-10-13 |
IT1219906B (it) | 1990-05-24 |
SE8801275A0 (sv) | 1988-10-19 |
GB2205495A (en) | 1988-12-14 |
GB8808125D0 (en) | 1988-05-11 |
US4855306A (en) | 1989-08-08 |
SE8801275D0 (sv) | 1988-04-08 |
DE3811274A1 (de) | 1988-10-27 |
KR880012227A (ko) | 1988-11-26 |
NL8800823A (nl) | 1988-11-01 |
IT8847814A0 (it) | 1988-04-05 |
FR2613623A1 (fr) | 1988-10-14 |
JPS63258819A (ja) | 1988-10-26 |
SE8801275L (sv) | 1988-10-19 |
DK193588A (da) | 1988-10-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK193588D0 (da) | Anvendelser af dopaminagonister | |
DK208188D0 (da) | Anvendelse af 17-ketosteroider | |
DK450189D0 (da) | Strimmel af sammenfoejede soem | |
DK363887D0 (da) | Anvendelse af bromcruptin | |
DK348385A (da) | Anvendelse af cyclosporiner | |
DK662687D0 (da) | Anvendelse af tricycliske carbazoloner | |
DK25389A (da) | Tolkning af elektriske diagrafier | |
DK549688A (da) | Fremstilling af peptider | |
DK185988D0 (da) | Anvendelse af antigen | |
DK360484A (da) | Modifikation af soja-isolat | |
DK38593D0 (da) | Alkoxymethylethere af glyceroler | |
DK102389D0 (da) | Anvendelse af interleukin | |
DK119688A (da) | 23-oxo- (-keto-) og 23-imino-derivater af mono- og diepoxy-ll-f28249-forbindelser | |
DK316589D0 (da) | Substituerede azacyclohexylderivater af rifamyciner | |
DK104489D0 (da) | Anvendelse af triazolderivater | |
DK562289A (da) | Anvendelse af somatostatiner | |
DK293787A (da) | Ekspression af en amyloglucosidase | |
DK426089D0 (da) | Omestring af phospholipider | |
DK541487D0 (da) | Sammenfoejning af materialer | |
DK251788D0 (da) | Stabile creatinamidinohydrolasemutanter | |
DK105089D0 (da) | Fremstilling af bis(amin-holdige)benzendioler | |
DK487289D0 (da) | Omestring af phospholipider | |
DK153045C (da) | Sammenkobling af fortrinsvis langstrakte elementer | |
DK621088D0 (da) | Theemballage af theposetypen | |
DK531987A (da) | Oprensning af antistoffer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AHB | Application shelved due to non-payment |